immune system
|
• spleen mass is significantly increased relative to C3 /Faslpr or single Faslpr mutants at 17 weeks of age
|
|
• lymph node mass is increased relative to C3-null, Faslpr or single Faslpr mutants at 13 and 17 weeks of age
|
|
• frequency of antibody-secreting cells (ASCs) or antibody-forming cells (AFCs) is significantly increased in spleen and bone marrow compared to C3-deficient Fas mutants
|
|
• titers of serum ANA are significantly increased at 10, 13, and 17 weeks
|
|
• anti-dsDNA titers are elevated significantly at 17 weeks
|
hematopoietic system
|
• spleen mass is significantly increased relative to C3 /Faslpr or single Faslpr mutants at 17 weeks of age
|
renal/urinary system
|
• increased IgG deposition relative to C3/Fas mutants is observed in kidney sections
|
|
• more severe glomerular abnormalities are observed relative to C3/Fas mutants
|
growth/size/body
|
• spleen mass is significantly increased relative to C3 /Faslpr or single Faslpr mutants at 17 weeks of age
|


Analysis Tools